<strong>Purpose:</strong> <span style="font-family:""><span style="font-family:Verdana;">To determine the prevalence of cutaneous disorders of PCOS and indicate the spe...<strong>Purpose:</strong> <span style="font-family:""><span style="font-family:Verdana;">To determine the prevalence of cutaneous disorders of PCOS and indicate the specific cutaneous lesions that have reliable association with PCOS. </span><b><span style="font-family:Verdana;">Methods: </span></b><span style="font-family:Verdana;">134 female participants had met the criteria to be diagnosed as PCOS</span></span><span style="font-family:Verdana;">.</span><b><span style="font-family:""> </span></b><span style="font-family:""><span style="font-family:Verdana;">Dermatological examination regarding hirsutism, acne, androgenic alopecia and acanthosis nigricans as well as any other cutaneous manifestations and assessment of each as regards duration, distribution and scoring was done. Hormonal assay for FSH/LH was done together with ultrasound examination. </span><b><span style="font-family:Verdana;">Results: </span></b><span style="font-family:Verdana;">The study included 134 female participants </span></span><span style="font-family:Verdana;">who </span><span style="font-family:Verdana;">had met the criteria to be diagnosed as PCOS</span><span style="font-family:Verdana;">;</span><span style="font-family:Verdana;"> the range of age was 18 </span><span style="font-family:Verdana;">-</span><span style="font-family:Verdana;"> 35 years, with a mean (26.31 ± 4.47 years). Among the PCOS patients at least one cutaneous disorder was found in 18 patients (13.4%), two cutaneous disorders in 44 patients (32.8%), three cutaneous disorders in 47 patients (35.1%), four cutaneous disorders in 24</span><span style="font-family:""> </span><span style="font-family:Verdana;">(17.9%) and five cutaneous disorders were found in only one patient (0.7%). Statistically, there was a significant positive correlations between hirsutism, acne, acanthosis nigricans and LH/F.S.H ratio (p < 0.001), and total testosterone level (p = 0.019, p < 0.001, p < 0.001) respectively. Statistically, there was non</span><span style="font-family:Verdana;">-</sp展开更多
文摘<strong>Purpose:</strong> <span style="font-family:""><span style="font-family:Verdana;">To determine the prevalence of cutaneous disorders of PCOS and indicate the specific cutaneous lesions that have reliable association with PCOS. </span><b><span style="font-family:Verdana;">Methods: </span></b><span style="font-family:Verdana;">134 female participants had met the criteria to be diagnosed as PCOS</span></span><span style="font-family:Verdana;">.</span><b><span style="font-family:""> </span></b><span style="font-family:""><span style="font-family:Verdana;">Dermatological examination regarding hirsutism, acne, androgenic alopecia and acanthosis nigricans as well as any other cutaneous manifestations and assessment of each as regards duration, distribution and scoring was done. Hormonal assay for FSH/LH was done together with ultrasound examination. </span><b><span style="font-family:Verdana;">Results: </span></b><span style="font-family:Verdana;">The study included 134 female participants </span></span><span style="font-family:Verdana;">who </span><span style="font-family:Verdana;">had met the criteria to be diagnosed as PCOS</span><span style="font-family:Verdana;">;</span><span style="font-family:Verdana;"> the range of age was 18 </span><span style="font-family:Verdana;">-</span><span style="font-family:Verdana;"> 35 years, with a mean (26.31 ± 4.47 years). Among the PCOS patients at least one cutaneous disorder was found in 18 patients (13.4%), two cutaneous disorders in 44 patients (32.8%), three cutaneous disorders in 47 patients (35.1%), four cutaneous disorders in 24</span><span style="font-family:""> </span><span style="font-family:Verdana;">(17.9%) and five cutaneous disorders were found in only one patient (0.7%). Statistically, there was a significant positive correlations between hirsutism, acne, acanthosis nigricans and LH/F.S.H ratio (p < 0.001), and total testosterone level (p = 0.019, p < 0.001, p < 0.001) respectively. Statistically, there was non</span><span style="font-family:Verdana;">-</sp
